Francesco Vetrini

8.8k total citations · 3 hit papers
31 papers, 5.3k citations indexed

About

Francesco Vetrini is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Francesco Vetrini has authored 31 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Francesco Vetrini's work include Virus-based gene therapy research (8 papers), Genomics and Rare Diseases (5 papers) and RNA Interference and Gene Delivery (4 papers). Francesco Vetrini is often cited by papers focused on Virus-based gene therapy research (8 papers), Genomics and Rare Diseases (5 papers) and RNA Interference and Gene Delivery (4 papers). Francesco Vetrini collaborates with scholars based in United States, Italy and Czechia. Francesco Vetrini's co-authors include Andrea Ballabio, Carmine Settembre, Tuong Huynh, Diego L. Medina, Serkan Erdin, Moisés Garcı́a-Arencibia, Pasqualina Colella, Marco Sardiello, Vinicia Assunta Polito and David C. Rubinsztein and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Francesco Vetrini

30 papers receiving 5.3k citations

Hit Papers

TFEB Links Autophagy to Lysosomal Biogenesis 2011 2026 2016 2021 2011 2012 2013 500 1000 1.5k 2.0k

Peers

Francesco Vetrini
Tuong Huynh United States
José A. Martina United States
Ryan C. Russell United States
Shouqing Luo United Kingdom
Ian G. Ganley United Kingdom
Farah H. Siddiqi United Kingdom
Seung‐Hyun Ro United States
Tuong Huynh United States
Francesco Vetrini
Citations per year, relative to Francesco Vetrini Francesco Vetrini (= 1×) peers Tuong Huynh

Countries citing papers authored by Francesco Vetrini

Since Specialization
Citations

This map shows the geographic impact of Francesco Vetrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Vetrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Vetrini more than expected).

Fields of papers citing papers by Francesco Vetrini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Vetrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Vetrini. The network helps show where Francesco Vetrini may publish in the future.

Co-authorship network of co-authors of Francesco Vetrini

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Vetrini. A scholar is included among the top collaborators of Francesco Vetrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Vetrini. Francesco Vetrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Conboy, Erin, et al.. (2024). Further evidence of involvement of ITSN1 in autosomal dominant neurodevelopmental disorder. Clinical Genetics. 105(4). 455–456. 1 indexed citations
3.
Nasır, Abdul, et al.. (2024). Undiagnosed rare disease clinic identifies a novel UBE3A variant in two sisters with Angelman syndrome: The end of a diagnostic odyssey. Congenital Anomalies. 64(3). 155–160. 1 indexed citations
5.
Shibao, Cyndya A., Karen M. Joos, John A. Phillips, et al.. (2021). Familial Autonomic Ganglionopathy Caused by Rare CHRNA3 Genetic Variants. Neurology. 97(2). e145–e155. 8 indexed citations
6.
Pratt, Victoria M., Amy Turner, Ulrich Broeckel, et al.. (2021). Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX. Journal of Molecular Diagnostics. 23(8). 952–958. 11 indexed citations
7.
Prior, Thomas W., Pınar Bayrak‐Toydemir, Rong Mao, et al.. (2020). Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing. Journal of Molecular Diagnostics. 23(1). 103–110. 8 indexed citations
8.
Settembre, Carmine, Rossella De Cegli, Gelsomina Mansueto, et al.. (2013). TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nature Cell Biology. 15(6). 647–658. 779 indexed citations breakdown →
9.
Pastore, Nunzia, Edoardo Nusco, Pasquale Piccolo, et al.. (2013). Improved Efficacy and Reduced Toxicity by Ultrasound-Guided Intrahepatic Injections of Helper-Dependent Adenoviral Vector in Gunn Rats. Human Gene Therapy Methods. 24(5). 321–327. 7 indexed citations
10.
Piccolo, Pasquale, Francesco Vetrini, Pratibha Mithbaokar, et al.. (2013). SR-A and SREC-I Are Kupffer and Endothelial Cell Receptors for Helper-dependent Adenoviral Vectors. Molecular Therapy. 21(4). 767–774. 40 indexed citations
11.
Pastore, Nunzia, Edoardo Nusco, Jana Vaníková, et al.. (2012). Sustained Reduction of Hyperbilirubinemia in Gunn Rats After Adeno-Associated Virus-Mediated Gene Transfer of Bilirubin UDP-Glucuronosyltransferase Isozyme 1A1 to Skeletal Muscle. Human Gene Therapy. 23(10). 1082–1089. 6 indexed citations
12.
Vetrini, Francesco & Philip Ng. (2011). Liver-Directed Gene Therapy with Helper-Dependent Adenoviral Vectors: Current State of the Art and Future Challenges. Current Pharmaceutical Design. 17(24). 2488–2499. 14 indexed citations
13.
Settembre, Carmine, Chiara Di Malta, Vinicia Assunta Polito, et al.. (2011). TFEB Links Autophagy to Lysosomal Biogenesis. Science. 332(6036). 1429–1433. 2496 indexed citations breakdown →
14.
Shaw, Amanda Rosewell & Francesco Vetrini. (2011). Helper-Dependent Adenoviral Vectors. Journal of Genetic Syndromes & Gene Therapy. 2(2). 25 indexed citations
15.
Khare, Reeti, Shannon M. May, Francesco Vetrini, et al.. (2011). Generation of a Kupffer Cell-evading Adenovirus for Systemic and Liver-directed Gene Transfer. Molecular Therapy. 19(7). 1254–1262. 66 indexed citations
16.
Vetrini, Francesco, Nicola Brunetti‐Pierri, Donna Palmer, et al.. (2010). Vasoactive Intestinal Peptide Increases Hepatic Transduction and Reduces Innate Immune Response Following Administration of Helper-dependent Ad. Molecular Therapy. 18(7). 1339–1345. 7 indexed citations
17.
Vetrini, Francesco & Philip Ng. (2010). Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives. Viruses. 2(9). 1886–1917. 42 indexed citations
18.
Engler, Tatjana, Erika Schmidt, Francesco Vetrini, et al.. (2010). Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells. Molecular Therapy. 19(1). 83–92. 56 indexed citations
19.
Giordano, Francesca, et al.. (2007). FGF and EGF differently affect differentiation of murine retinal stem cells in vitro. 13. 1842–1850. 1 indexed citations
20.
Vetrini, Francesco, Roberta Tammaro, Sergio Bondanza, et al.. (2006). Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides. Human Mutation. 27(5). 420–426. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026